Offer - Urjas Oil for just ₹ 1
Fulvetraz 250 Injection is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Breast Cancer.
The correct dosage of Fulvetraz 250 Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Fulvetraz 250 Injection include Urinary tract infection, Flu-like Symptoms. Some other side effects of Fulvetraz 250 Injection have been listed ahead. These side effects of Fulvetraz 250 Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Fulvetraz 250 Injection has a Severe effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Fulvetraz 250 Injection related warnings talks about Fulvetraz 250 Injection's effects on the liver, heart and kidney.
Fulvetraz 250 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Fulvetraz 250 Injection in conditions like Thrombocytopenia and ITP. Other conditions have been mentioned below in the Fulvetraz 250 Injection contraindications section.
Drug interactions for Fulvetraz 250 Injection have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Fulvetraz 250 Injection is not safe while driving, and is is not addictive in nature.
Fulvetraz 250 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Fulvetraz 250 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Fulvetraz. If you are pregnant, do not take Fulvetraz without a doctor's advice.
Is the use of Fulvetraz 250 Injection safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Fulvetraz. Immediately discontinue Fulvetraz if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Fulvetraz 250 Injection on the Kidneys?
Fulvetraz rarely harms the kidneys.
What is the effect of Fulvetraz 250 Injection on the Liver?
Fulvetraz can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Fulvetraz 250 Injection on the Heart?
Fulvetraz has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Fulvetraz 250 Injection unless your doctor advises you to do so -
Is this Fulvetraz 250 Injection habit forming or addictive?
Forming a habit of Fulvetraz 250 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Fulvetraz 250 Injection as you may feel sleepy.
Is it safe?
Fulvetraz 250 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Fulvetraz 250 Injection in mental disorders is not effective.
Interaction between Food and Fulvetraz 250 Injection
Due to the absence of research, it is difficult to say how Fulvetraz 250 Injection and food will interact.
Interaction between Alcohol and Fulvetraz 250 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Fulvetraz 250 Injection.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Faslodex® (fulvestrant)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 313